Recital 5, Decision_act (EU) 2026/582

In forcesince 11 Mar 2026

In addition, since the adoption of Implementing Decision (EU) 2026/484, there have been further outbreaks of foot and mouth disease in establishments in the Larnaca district in Cyprus, which were confirmed between 21 February and 4 March 2026, including outside the areas listed as protection and surveillance zones in the Annex to Implementing Decision (EU) 2026/484. Therefore, it is necessary to urgently establish restricted zones at Union level to take account of those further outbreaks.

  • celex=32026D0484
  • num:eu=2026/484